Delivery Order SPE2DE24D0013-SPE2D626F6630
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,039.40 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025, with a completion deadline of November 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at the contractor's Sunnyvale location. The award falls under the Defense Logistics Agency's procurement operations, which...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $1,417.52 on October 22, 2025, by the Defense Logistics Agency Medical Supply Chain under a firm fixed-price contract structure. The delivery order, designated XPRSMVP-10, is scheduled for completion by October 29, 2025, with performance occurring at Cepheid's Sunnyvale facility. This award was made without a set-aside designation, reflecting Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,951.40 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued on September 18, 2025, carries no set-aside designation and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is likely associated...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a delivery order valued at $3,240 from the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with ultimate completion targeted for November 7, 2025. This firm fixed-price delivery order, issued under contract 4569883320 (GXTV-10), carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,880.04 by the Defense Logistics Agency Medical Supply Chain on October 17, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by October 24, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F6630Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $1,750 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 29, 2025, with a completion date of November 5, 2025. The delivery order, designated GXMRSA-NXG-10 with contract number 4569867034, carries no set-aside designation and represents a continuation of Cepheid's extensive federal procurement relationship as a primary supplier of molecular diagnostic solutions. The place of performance is located in Sunnyvale, California. This delivery order falls within the context of Cepheid's broader federal contracting portfolio, which includes substantial prime Indefinite Delivery Contracts with the Department of Veterans Affairs, including a $32.8 million single-award IDC with VISN 6 extending through September 30, 2030. Cepheid specializes in providing diagnostic reagents, test kits, and maintenance services for its GeneXpert diagnostic platform, supporting federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard in testing for infectious diseases including COVID-19, influenza, tuberculosis, and other conditions. The company's consistent use of firm fixed-price structures across federal contracts demonstrates its competitive positioning in the molecular diagnostics procurement market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/29/25 |